Dalton Venture Honored on Diyixinsheng's Q2 2026 China Most Active Investors Rankings, Winning "Top 30 Most Active Early-Stage Investment Institutions" and "Top 10 Most Active Healthcare Investment Institutions" | Dalton Honor
Recently, Diyixinsheng released its Q2 2026 China Most Active Investment Firms rankings. The list evaluated firms across multiple dimensions including investment activity, fundraising, exits, IPOs, service transactions, post-investment tech support, and market influence. **Dalton Venture was honored with two awards: "Top 30 Most Active Early-Stage Investment Firms" and "Top 10 Most Active Investment Firms in Healthcare."**
Background
Recently, Diyixinsheng released its Q2 2026 China Most Active Institutions rankings. The evaluation covered multiple dimensions including investment, fundraising, exits, IPOs, service transactions, tech post-investment support, and market influence. Dalton Venture was named to the "Top 30 Most Active Early-Stage Investment Institutions" and "Top 10 Most Active Healthcare Investment Institutions."
To better assess deal flow in China's new-economy equity investment market, Diyixinsheng has conducted nearly 2,100 surveys across 22 consecutive quarters over six years. The organization has maintained its focus on early-stage investment firms, venture capital institutions, private equity firms, financial advisors, and LPs — evaluating them across investment, fundraising, exits, IPOs, service transactions, tech post-investment support, and market influence to produce its Invest in China — China Investment Institutions Rankings. The goal: to create what it calls "a true founder's guide to fundraising and LP's investment reference."
The Q2 2026 China Most Active Institutions rankings comprise two categories: "Comprehensive Rankings" and "Sector Rankings."
For this edition, Diyixinsheng organized surveys of nearly 100 institutions during Q2 2026 (the 22nd quarterly survey overall), evaluating domestic firms based on Q2 2026 investment/transaction volume, investment/transaction value, fundraising and IPO performance, market influence, and the presence or absence of major negative information. Data sources consisted primarily of self-reported institutional data and survey findings, supplemented by public data from ITjuzi and Tianyancha.
Dalton Venture received two awards in the Q2 2026 China Most Active Institutions Comprehensive Rankings: "Top 30 Most Active Early-Stage Investment Institutions" and "Top 10 Most Active Healthcare Investment Institutions."
Dalton Venture
Top 30 Most Active Early-Stage Investment Institutions in China
Dalton Venture
Top 10 Most Active Healthcare Investment Institutions
ID: daltonventure
Long press to follow
RECOMMEND
Recommended Reading
Dalton Honor
Dalton Venture named to Cailianshe Annual Best Investment Firms Top 50
Dalton Venture founding managing partner Qi Sun named to 2025 "Top 30 Angel Investors" list
Dalton Venture named to Rongzi China 2025 China Top 100 VC Firms
Dalton Venture named Rongzi China 2024-2025 "Best Investment Firm in China's Healthcare Sector"
Dalton Venture named to LP Club "2024 Top 30 Early-Stage Investment Firms Most Followed by LPs"
Dalton Venture named to ChinaVenture "2023 China Best Early-Stage Investment Firms Top 10"
Qi Sun named to "ChinaVenture 2022-2023 Best Early-Stage Investors Top 50"
Dalton Venture named to CVCRI "2023 China Best Healthcare Investment Firms Top 30"
Dalton Venture named to Touzijia "2022-2023 Best VC Firms Top 60"
Dalton Venture named to Yicai "Annual Best Investment Firms Top 50"
Dalton Venture named to FOFweekly 2023 "Investment Firm Soft Power Rankings — Value Creation Top 20"
Dalton Venture named to ChinaVenture 2022 "China Best VC Firms Top 100"
Dalton Venture named to ChinaVenture 2022 "Best Medical Device Investment Firms Top 20"
Dalton Venture named to VBData "Pengcheng Award — Annual Medical Device Investment Firms Top 20"
Dalton Venture named to FOFWEEKLY "2021 Top 20 Healthcare Investment Firms Most Followed by LPs"
Dalton Venture makes "China Best VC Firms Top 100" for four consecutive years
Dalton Venture named to Touzijia "2021 Best Investment Firms in Healthcare Top 20"
Dalton Venture named to CVCRI "2021 China Best Healthcare Investment Firms Top 30"
Qi Sun named to "ChinaVenture 2020 China Best Early-Stage Investors Top 50"
Dalton Venture named "2020-2021 Top 40 Investment Firms Most Favored by LPs"
Dalton Venture named "2020-2021 Best Early-Stage Investment Firm in China's Healthcare Industry"
Dalton Venture makes "China Best VC Firms Top 100" for three consecutive years
Dalton Venture receives honors including "2020 Best Investment Firms in Healthcare Top 30"
Dalton Venture named to CVCRI "2020 China Best Healthcare Investment Firms Top 30"